Trial NCT00005067

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02323
Secondary IDs: CDR0000067672 UPCC 6899

Last trial update was posted on 2013-01-16

MeSH Interventions

Motexafin lutetium

MeSH Conditions

Prostatic Neoplasms Recurrence

Other Conditions

Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID